Characterisation of COPD heterogeneity in the ECLIPSE cohort.

PubWeight™: 5.17‹?› | Rank: Top 1%

🔗 View Article (PMC 2944278)

Published in Respir Res on September 10, 2010

Authors

Alvar Agusti1, Peter M A Calverley, Bartolome Celli, Harvey O Coxson, Lisa D Edwards, David A Lomas, William MacNee, Bruce E Miller, Steve Rennard, Edwin K Silverman, Ruth Tal-Singer, Emiel Wouters, Julie C Yates, Jørgen Vestbo, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators

Author Affiliations

1: Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona, Spain. alvar.agusti@clinic.ub.es

Associated clinical trials:

Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints (ECLIPSE) | NCT00292552

Phenotypes of COPD in Central and Eastern Europe (POPE) | NCT02119494

Dyspnea in COPD: Relationship With Exacerbations Frequency (DPE) | NCT02113839

Articles citing this

(truncated to the top 100)

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30

Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax (2014) 2.95

Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ (2011) 2.88

Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.82

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52

Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med (2013) 1.82

Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med (2014) 1.80

Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD. PLoS Genet (2015) 1.52

Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Int J Chron Obstruct Pulmon Dis (2012) 1.50

Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD). Am J Respir Crit Care Med (2015) 1.50

Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. Chest (2014) 1.48

Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax (2014) 1.48

Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis (2012) 1.47

Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD. Chronic Obstr Pulm Dis (2015) 1.43

Quantitative computed tomography in COPD: possibilities and limitations. Lung (2011) 1.35

Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.29

Dynamic data during hypotensive episode improves mortality predictions among patients with sepsis and hypotension. Crit Care Med (2013) 1.24

Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis (2014) 1.23

Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One (2014) 1.23

Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulm Med (2013) 1.21

Cytokine inhibition in the treatment of COPD. Int J Chron Obstruct Pulmon Dis (2014) 1.16

Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res (2011) 1.15

Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One (2012) 1.15

Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med (2013) 1.14

Biomarkers of progression of chronic obstructive pulmonary disease (COPD). J Thorac Dis (2014) 1.14

Early identification of small airways disease on lung cancer screening CT: comparison of current air trapping measures. Lung (2012) 1.14

Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis (2014) 1.11

Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet (2015) 1.11

The relationship between lung function impairment and quantitative computed tomography in chronic obstructive pulmonary disease. Eur Radiol (2011) 1.09

COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis (2013) 1.09

Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2014) 1.09

Factors associated with change in exacerbation frequency in COPD. Respir Res (2013) 1.08

Diagnosis and early detection of COPD using spirometry. J Thorac Dis (2014) 1.05

A telehealth program for self-management of COPD exacerbations and promotion of an active lifestyle: a pilot randomized controlled trial. Int J Chron Obstruct Pulmon Dis (2014) 1.05

The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis. BMC Pulm Med (2013) 1.05

Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study. Tuberc Respir Dis (Seoul) (2014) 1.05

Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PLoS One (2012) 1.04

Chronic obstructive pulmonary disease. Indian J Med Res (2013) 1.02

Chronic obstructive pulmonary disease prevalence in Lebanon: a cross-sectional descriptive study. Clin Epidemiol (2011) 1.01

Nipping it in the bud: An inspiring mission for prevention and management of COPD. J Thorac Dis (2012) 1.01

COPD and disease-specific health status in a working population. Respir Res (2013) 1.00

Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis (2015) 0.99

Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis (2014) 0.99

The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. Curr Opin Pulm Med (2015) 0.98

Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes. Med Clin North Am (2012) 0.98

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir Res (2013) 0.98

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.97

Autoreactive T Cells in Human Smokers is Predictive of Clinical Outcome. Front Immunol (2012) 0.96

Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls. Int J Chron Obstruct Pulmon Dis (2015) 0.96

Characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian cities. Int J Chron Obstruct Pulmon Dis (2013) 0.95

Symptom variability in COPD: a narrative review. Int J Chron Obstruct Pulmon Dis (2013) 0.95

Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med (2014) 0.93

Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials. Proc Am Thorac Soc (2011) 0.92

Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ Open (2013) 0.92

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial. BMC Pulm Med (2014) 0.92

The Saudi Guidelines for the Diagnosis and Management of COPD. Ann Thorac Med (2014) 0.92

Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chron Obstruct Pulmon Dis (2015) 0.91

Chronic obstructive pulmonary disease severity is associated with severe pneumonia. Ann Thorac Med (2015) 0.91

A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.90

Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Biomed Res Int (2014) 0.89

Causes of Death Associated With Prolonged TV Viewing: NIH-AARP Diet and Health Study. Am J Prev Med (2015) 0.89

Impaired health status and care dependency in patients with advanced COPD or chronic heart failure. Qual Life Res (2011) 0.89

Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study. Respir Res (2011) 0.89

The role of microparticles in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.89

Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy. Int J Chron Obstruct Pulmon Dis (2016) 0.89

Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res (2012) 0.88

RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care. BMC Pulm Med (2013) 0.87

Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? Int J Chron Obstruct Pulmon Dis (2014) 0.87

What pulmonologists think about the asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis (2015) 0.87

Physical inactivity in COPD and increased patient perception of dyspnea. Int J Chron Obstruct Pulmon Dis (2012) 0.86

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease. Thorax (2012) 0.86

New developments in the assessment of COPD: early diagnosis is key. Int J Chron Obstruct Pulmon Dis (2014) 0.86

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis. BMJ Open (2013) 0.85

Distinguishing adult-onset asthma from COPD: a review and a new approach. Int J Chron Obstruct Pulmon Dis (2014) 0.85

Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2015) 0.85

Characteristics of Dutch and Swiss primary care COPD patients - baseline data of the ICE COLD ERIC study. Clin Epidemiol (2011) 0.85

Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res (2014) 0.84

Advanced imaging in COPD: insights into pulmonary pathophysiology. J Thorac Dis (2014) 0.84

Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study. Clin Transl Med (2016) 0.84

Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. Br J Clin Pharmacol (2014) 0.84

Integrative genomics of chronic obstructive pulmonary disease. Biochem Biophys Res Commun (2014) 0.82

DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease. Respir Res (2014) 0.82

Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res (2014) 0.82

Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management. J Transl Med (2014) 0.81

Bronchiectasis in the Last Five Years: New Developments. J Clin Med (2016) 0.81

Oxygen-weighted Hyperpolarized (3)He MR Imaging: A Short-term Reproducibility Study in Human Subjects. Radiology (2015) 0.81

Determinants for changing the treatment of COPD: a regression analysis from a clinical audit. Int J Chron Obstruct Pulmon Dis (2016) 0.81

Higher risk of wheeze in female than male smokers. Results from the Swedish GA 2 LEN study. PLoS One (2013) 0.81

A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. PLoS One (2013) 0.81

Fracture prevention in COPD patients; a clinical 5-step approach. Respir Res (2015) 0.80

The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis (2014) 0.80

A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease. BMC Syst Biol (2014) 0.80

Relationship between femur neck bone mineral density and prevalent chronic obstructive pulmonary disease (COPD) or COPD mortality in older non-Hispanic white adults from NHANES III. Osteoporos Int (2014) 0.80

Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype. Biochem Biophys Res Commun (2011) 0.80

Analyzing networks of phenotypes in complex diseases: methodology and applications in COPD. BMC Syst Biol (2014) 0.80

Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease. PLoS One (2015) 0.80

Diagnosis, assessment, and phenotyping of COPD: beyond FEV1. Int J Chron Obstruct Pulmon Dis (2016) 0.80

The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res (2016) 0.80

Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease. Transl Res (2015) 0.79

Articles cited by this

Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41

ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 20.55

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60

The natural history of chronic airflow obstruction. Br Med J (1977) 13.04

Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J (2008) 4.53

Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70

Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J (1997) 3.29

Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med (2007) 2.80

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J (2010) 2.77

Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr (2005) 2.74

Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest (2007) 2.67

The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med (2009) 2.60

Gender and COPD in patients attending a pulmonary clinic. Chest (2005) 2.59

Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00

Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med (2006) 1.98

Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.90

Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest (2008) 1.89

Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One (2007) 1.88

Issues concerning health-related quality of life in COPD. Chest (1995) 1.64

Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. BMJ (2010) 1.43

COPD, a multicomponent disease: implications for management. Respir Med (2005) 1.36

The heterogeneity of chronic obstructive pulmonary disease. Thorax (2000) 1.25

NICE guidance for COPD. Thorax (2004) 1.10

Articles by these authors

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86

A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 17.19

The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08

Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2003) 10.97

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med (2007) 8.06

Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 7.67

Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67

High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20

A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet (2009) 6.93

Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med (2014) 6.29

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med (2008) 6.17

Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med (2011) 5.69

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65

Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol (2004) 5.57

Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet (2009) 5.51

Genomic screening and replication using the same data set in family-based association testing. Nat Genet (2005) 5.44

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92

Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med (2011) 4.75

Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation (2005) 4.71

PBAT: tools for family-based association studies. Am J Hum Genet (2004) 4.68

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet (2009) 4.40

Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med (2011) 4.16

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98

MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data. Lancet (2009) 3.93

An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 3.92

Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91

A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet (2009) 3.78

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J (2004) 3.77

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 3.69

Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ (2011) 3.61

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med (2011) 3.58

A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics (2003) 3.52

Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44

Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med (2012) 3.44

Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet (2009) 3.41

What is chronic obstructive pulmonary disease anyway?: Continua, categories, cut points, and moving beyond spirometry. Am J Respir Crit Care Med (2013) 3.39

On the replication of genetic associations: timing can be everything! Am J Hum Genet (2008) 3.32

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30

Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol (2005) 3.12

Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med (2007) 3.05

The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med (2004) 3.02

Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med (2008) 3.00

Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med (2012) 3.00

The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med (2007) 2.91

FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J (2013) 2.87

COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J (2013) 2.81

Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med (2004) 2.62

'Highlights from this issue’ in the November issue of Thorax. Thorax (2013) 2.59

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA (2013) 2.59

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52